for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Tibet Rhodiola Pharmaceutical Holding Co

600211.SS

Latest Trade

37.72CNY

Change

0.26(+0.69%)

Volume

924,717

Today's Range

37.16

 - 

37.85

52 Week Range

24.65

 - 

44.30

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
37.46
Open
37.31
Volume
924,717
3M AVG Volume
38.17
Today's High
37.85
Today's Low
37.16
52 Week High
44.30
52 Week Low
24.65
Shares Out (MIL)
179.62
Market Cap (MIL)
6,728.54
Forward P/E
18.82
Dividend (Yield %)
0.99

Latest Developments

More

Tibet Rhodiola Pharmaceutical Plans Share Buyback Worth 70-140 Mln Yuan Within 12 Months

Tibet Rhodiola Pharmaceutical Holding to pay cash dividend of 0.385 yuan per share on May 28

Tibet Rhodiola Pharmaceutical Holding says unfrozen of 11.13 pct stake

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Tibet Rhodiola Pharmaceutical Holding Co

TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The Company conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.

Industry

Major Drugs

Contact Info

No. 19, Beijing Middle Road

+86.891.6835809

http://www.xzyy.cn

Executive Leadership

Dabin Chen

Chairman of the Board

Yucheng Zhou

Vice Chairman of the Board

Yuandong Guo

General Manager

Chunyan Yang

Deputy General Manager

Lan Liu

Secretary of the Board

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

0.8K

2017

0.9K

2018

1.0K

2019(E)

1.4K
EPS (CNY)

2016

1.360

2017

1.370

2018

1.200

2019(E)

1.990
Price To Earnings (TTM)
27.34
Price To Sales (TTM)
5.64
Price To Book (MRQ)
2.98
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
11.18
Return on Equity (TTM)
9.98

Latest News

BRIEF-Tibet Rhodiola Pharmaceutical Holding receives support funds worth 28.8 mln yuan

* Says it received support funds worth 28.8 million yuan on Feb. 8

BRIEF-Tibet Rhodiola Pharmaceutical Holding says unfrozen of 11.13 pct stake

* Says 11.13 percent stake held by co's shareholder was unfrozen on Nov. 17

BRIEF-Tibet Rhodiola Pharmaceutical says 2017 H1 dividend payment date

* Says it will pay a cash dividend of 0.332 yuan per share(before tax) for 2017 H1 to shareholders of record on Sept. 27

BRIEF-Tibet Rhodiola Pharmaceutical Holding announces change in accounting policy

* Says it changes accounting policy based on accounting standards for business enterprises

BRIEF-Tibet Rhodiola Pharmaceutical Holding raises 1.24 bln yuan through private placement

* Says it issued 34 million A shares of its common stock through private placement and raised 1.24 billion yuan in total

BRIEF-Tibet Rhodiola Pharma cuts share issue size

* Says it cuts share issue size to 1.24 billion yuan ($180.73 million) from 1.36 billion yuan previously

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up